 The FDA is so concerned about making the federal courts show deference to its decision making that it is ignoring its statutory obligations and it's overlooking its requirements from the APA. And where it does change its longstanding position, as our questioner asked, it has to adequately explain itself and it has to show that there are good reasons for this new policy. And that has not happened here.